NO.1 PHARMACY issues a profit warning, expecting a net profit attributable to the parent company of 12.6 million to 15.8 million yuan for the half-year, a year-on-year decrease of 87.83% to 90.29%
According to the Zhitong Finance APP, NO.1 PHARMACY announced that the company expects to achieve a net profit attributable to the owners of the parent company of 12.6 million to 15.8 million yuan for the first half of 2025, a year-on-year decrease of 87.83% to 90.29% compared to the same period last year. The decline in net profit attributable to the owners of the parent company during this period is mainly due to the existence of housing expropriation compensation in the same period last year
According to the Zhitong Finance APP, NO.1 PHARMACY (600833.SH) announced that the company expects to achieve a net profit attributable to the owners of the parent company of 12.6 million to 15.8 million yuan in the first half of 2025, a year-on-year decrease of 87.83% to 90.29% compared to the same period last year.
The decline in net profit attributable to the owners of the parent company during this period is mainly due to the existence of housing expropriation compensation in the same period last year
